newswire

Tiziana Life Sciences to Ring the Closing Bell at Nasdaq

BOSTON, Dec. 17, 2025 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing…

2 months ago

Pathway Healths Lisa Thomson Receives 2026 McKnights Pinnacle Award

LAKE ELMO, Minn., Dec. 16, 2025 (GLOBE NEWSWIRE) -- Pathway Health, a leading provider of health care consulting services, interim…

2 months ago

Bring the Cheer, Pack the Gear: Game On This Holiday Season

LAUSANNE, Switzerland, Dec. 16, 2025 (GLOBE NEWSWIRE) -- As the year winds down and millions prepare to visit family or…

2 months ago

Cholame Finance Academy Finalizes Comprehensive Data Protection Upgrade with Rupert Ellingtons Oversight

Cholame Finance Academy, guided by Rupert Ellington, has completed a comprehensive data security upgrade to reinforce internal protection, system resilience,…

2 months ago

VivoPower Announces Update to Annual General Meeting

LONDON, Dec. 15, 2025 (GLOBE NEWSWIRE) -- VivoPower International PLC (NASDAQ: VVPR), an English company (the "Company"), today announced an…

2 months ago

Kyverna Therapeutics to Report Topline Results from Registrational Phase 2 KYSA-8 Trial of KYV-101 in Stiff Person Syndrome

– Company to host live webcast and conference call Monday, December 15, 2025 at 8:00 am ET – December 14,…

2 months ago

Vaxxas Secures TGA Licence to Manufacture Therapeutic Goods

BRISBANE, Australia and CAMBRIDGE, Mass., Dec. 14, 2025 (GLOBE NEWSWIRE) -- Australian biotechnology pioneer Vaxxas Pty Ltd, has been granted…

2 months ago

Mutuum Finance (MUTM) Completes Smart Contracts in Preparation for Q4 2025 Testing

Dubai, UAE, Dec. 14, 2025 (GLOBE NEWSWIRE) -- Mutuum Finance (MUTM), a decentralized finance (DeFi) project focused on lending and…

2 months ago

Free Spins No Deposit Casino | Real Money Online Casino No Deposit Bonus By Cafe Casino

New York City, NY, Dec. 13, 2025 (GLOBE NEWSWIRE) -- . Free spins no deposit casino bonuses have become one…

2 months ago

Milestone Receives FDA Approval of CARDAMYST (etripamil) as First and Only Self-Administered Nasal Spray for Adults with Paroxysmal Supraventricular Tachycardia (PSVT)

First FDA approved treatment in 30+ years for more than 2 million Americans with PSVT Novel nasal spray designed to rapidly…

2 months ago